TY - JOUR
T1 - Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone
AU - Norton, Emily S.
AU - Whaley, Lauren A.
AU - Jones, Vanessa K.
AU - Brooks, Mieu M.
AU - Russo, Marissa N.
AU - Morderer, Dmytro
AU - Jessen, Erik
AU - Schiapparelli, Paula
AU - Ramos-Fresnedo, Andres
AU - Zarco, Natanael
AU - Carrano, Anna
AU - Rossoll, Wilfried
AU - Asmann, Yan W.
AU - Lam, Tu Kiet T.
AU - Chaichana, Kaisorn L.
AU - Anastasiadis, Panos Z.
AU - Quiñones-Hinojosa, Alfredo
AU - Guerrero-Cázares, Hugo
N1 - Publisher Copyright:
© 2024 The Authors.
PY - 2024/8
Y1 - 2024/8
N2 - Glioblastoma (GBM) is the most prevalent and aggressive malignant primary brain tumor. GBM proximal to the lateral ventricles (LVs) is more aggressive, potentially because of subventricular zone contact. Despite this, cross-talk between GBM and neural stem/progenitor cells (NSC/NPCs) is not well understood. Using cell-specific proteomics, we show that LV-proximal GBM prevents neuronal maturation of NSCs through induction of senescence. In addition, GBM brain tumor-initiating cells (BTICs) increase expression of cathepsin B (CTSB) upon interaction with NPCs. Lentiviral knockdown and recombinant protein experiments reveal that both cell-intrinsic and soluble CTSB promote malignancy-associated phenotypes in BTICs. Soluble CTSB stalls neuronal maturation in NPCs while promoting senescence, providing a link between LV-tumor proximity and neurogenesis disruption. Last, we show LV-proximal CTSB up-regulation in patients, showing the relevance of this cross-talk in human GBM biology. These results demonstrate the value of proteomic analysis in tumor microenvironment research and provide direction for new therapeutic strategies in GBM.
AB - Glioblastoma (GBM) is the most prevalent and aggressive malignant primary brain tumor. GBM proximal to the lateral ventricles (LVs) is more aggressive, potentially because of subventricular zone contact. Despite this, cross-talk between GBM and neural stem/progenitor cells (NSC/NPCs) is not well understood. Using cell-specific proteomics, we show that LV-proximal GBM prevents neuronal maturation of NSCs through induction of senescence. In addition, GBM brain tumor-initiating cells (BTICs) increase expression of cathepsin B (CTSB) upon interaction with NPCs. Lentiviral knockdown and recombinant protein experiments reveal that both cell-intrinsic and soluble CTSB promote malignancy-associated phenotypes in BTICs. Soluble CTSB stalls neuronal maturation in NPCs while promoting senescence, providing a link between LV-tumor proximity and neurogenesis disruption. Last, we show LV-proximal CTSB up-regulation in patients, showing the relevance of this cross-talk in human GBM biology. These results demonstrate the value of proteomic analysis in tumor microenvironment research and provide direction for new therapeutic strategies in GBM.
UR - http://www.scopus.com/inward/record.url?scp=85200939183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85200939183&partnerID=8YFLogxK
U2 - 10.1126/sciadv.adn1607
DO - 10.1126/sciadv.adn1607
M3 - Article
C2 - 39110807
AN - SCOPUS:85200939183
SN - 2375-2548
VL - 10
JO - Science Advances
JF - Science Advances
IS - 32
M1 - adn1607
ER -